92 related articles for article (PubMed ID: 1336219)
1. [Topical administration of unfractionated and low molecular weight heparin for prevention of appositional thrombus formation].
Koppenhagen K; Häring R; Proksch W; Erdmann K; Leick M; Bundrock P; Franke J
Vasa Suppl; 1992; 35():99-100. PubMed ID: 1336219
[No Abstract] [Full Text] [Related]
2. [Low molecular weight heparin: favorable effect profile for prevention and therapy of venous thrombosis].
Marbet GA
Ther Umsch; 1992 Dec; 49(12):843-9. PubMed ID: 1336627
[TBL] [Abstract][Full Text] [Related]
3. [Prevention of thrombosis in surgery: low molecular weight heparin/standard heparin].
Weinand HA; Gehrke T; Krieg H; Brünner H
Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():1175-7. PubMed ID: 1983508
[TBL] [Abstract][Full Text] [Related]
4. [Prevention of thrombosis with unfractionated and low molecular weight heparin].
Breddin HK
Wien Med Wochenschr; 1989 Dec; 139(23):555-9. PubMed ID: 2560285
[TBL] [Abstract][Full Text] [Related]
5. Low-molecular-weight heparin vs. warfarin for prophylaxis against deep-vein thrombosis.
Hirsh J
N Engl J Med; 1994 Mar; 330(12):862-3. PubMed ID: 8114845
[No Abstract] [Full Text] [Related]
6. Effects of standard unfractionated and low-molecular-weight heparins on platelets of patients undergoing total hip replacement surgery.
Aulmann M; Kwasniki S; Böttiger BW; Meeder PJ
Beitr Infusionsther Transfusionsmed; 1997; 34():242-7. PubMed ID: 9356680
[TBL] [Abstract][Full Text] [Related]
7. The influence of low molecular weight heparin in combination with dihydroergotamine on experimental thrombosis and haemostasis.
Bergqvist D; Nilsson B
Thromb Haemost; 1987 Oct; 58(3):893-5. PubMed ID: 2829377
[TBL] [Abstract][Full Text] [Related]
8. Low molecular weight heparin (Alfa LHWH) compared with unfractionated heparin in prevention of deep-vein thrombosis after hip fractures.
Pini M; Tagliaferri A; Manotti C; Lasagni F; Rinaldi E; Dettori AG
Int Angiol; 1989; 8(3):134-9. PubMed ID: 2556484
[TBL] [Abstract][Full Text] [Related]
9. Prevention of thromboembolic disease in general surgery with enoxaparin (Clexane).
Samama M; Combe S
Acta Chir Scand Suppl; 1990; 556():91-5. PubMed ID: 1963022
[TBL] [Abstract][Full Text] [Related]
10. [Improved postoperative prevention of thrombosis in trauma surgery by dose adjusted low molecular weight heparin based on TAT and D-dimer values].
Hansen M; Mayer A; Peetz D; Hafner G; Prellwitz W; Rommens PM
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1213-7. PubMed ID: 9931839
[No Abstract] [Full Text] [Related]
11. [Prevention of thrombosis in minimally invasive surgery].
Harenberg J
Zentralbl Chir; 1994; 119(6):447-8. PubMed ID: 8091883
[No Abstract] [Full Text] [Related]
12. Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?
Agnelli G
Haematologica; 1995; 80(2 Suppl):78-83. PubMed ID: 7628776
[No Abstract] [Full Text] [Related]
13. Effects of low-molecular-weight and unfractionated heparin on trophoblast function.
Quenby S; Mountfield S; Cartwright JE; Whitley GS; Vince G
Obstet Gynecol; 2004 Aug; 104(2):354-61. PubMed ID: 15292011
[TBL] [Abstract][Full Text] [Related]
14. An overview of clinical trials of low molecular weight heparin fractions.
Levine MN; Hirsh J
Acta Chir Scand Suppl; 1988; 543():73-9. PubMed ID: 2847461
[TBL] [Abstract][Full Text] [Related]
15. [Unfractionated standard heparin versus low molecular weight heparins].
Schrader J; Haas S
Internist (Berl); 1993 Nov; 34(11):1053-7; discussion 1058. PubMed ID: 8282491
[No Abstract] [Full Text] [Related]
16. [Therapy of thromboses with low-molecular-weight heparins].
Haas S; Haas P
Wien Med Wochenschr; 1999; 149(2-4):39-45; discussion 45. PubMed ID: 10378321
[TBL] [Abstract][Full Text] [Related]
17. Experimental studies on the antithrombotic and haemorrhagic effects of heparin and a low molecular weight heparin derivative.
Kaiser B; Hauptmann J; Markwardt F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):119-25. PubMed ID: 2459005
[TBL] [Abstract][Full Text] [Related]
18. Unfractionated versus low-molecular-weight heparin for deep venous thrombosis.
Penner J
N Engl J Med; 1996 Aug; 335(9):671; author reply 671-2. PubMed ID: 8692247
[No Abstract] [Full Text] [Related]
19. [Prevention of thrombosis with low molecular weight heparin as the only substance and/or with DHE: results of clinical studies].
Koppenhagen K; Tröster E; Matthes M; Häring R
Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():1163-6. PubMed ID: 1983504
[TBL] [Abstract][Full Text] [Related]
20. [What is assured in drug prevention of thrombosis with special reference to low molecular weight heparin?].
Daiss W; Dölle W
Internist (Berl); 1989 Dec; 30(12):784-9. PubMed ID: 2559898
[No Abstract] [Full Text] [Related]
[Next] [New Search]
